David Bremseth

David Bremseth, Pharm.D., is a seasoned professional in clinical research and regulatory affairs with extensive experience in the medical device industry. Currently serving as the Clinical Research Integration Officer at the University of Minnesota since September 2012, David previously held leadership positions including Senior Operations Director at Schultze Diabetes Institute/University of Minnesota and Clinical and Regulatory Consultant at DLB Consulting. David has also been a Vice President in Clinical, Regulatory, and Quality at Pavad Medical and Restore Medical, contributing to the development of implants for obstructive sleep apnea, with Restore Medical being sold to Medtronic in 2008. Earlier career accomplishments include significant roles at Celleration, Antares Pharma, Ophan Medical, LecTec Corporation, and Pharmaceutical Research Associates. Educational qualifications include a Pharm.D. from The Ohio State University and a fellowship in Drug Development from the University of North Carolina at Chapel Hill.